A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact ...

This study provides valuable insights into the role of the NF-kB and IKK signaling pathways in γδ T cell development and survival, using robust genetic mouse models. While the research is ...

LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the ...

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

Lyell Immunopharma has acquired worldwide rights from ICT to LYL273, an advanced CAR T-cell candidate for metastatic ...

A UK-led team has discovered a previously unrecognized cancer cell type in treatment-resistant T-cell acute lymphoblastic ...

Researchers identified a key receptor that primes the formation of autoreactive B cells. Disrupting this pathway may be a ...

Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.

APOLLO study showed encouraging overall responses and favorable safety profile in relapsed/refractory B-cell lymphoma MT-601 demonstrated 66% ...

New research suggests that DNA variants help predict toxicity and response in CAR T-cell therapy for large B-cell lymphoma.

Researchers at Stanford have made a significant breakthrough in the field of stem cell transplants, pioneering a method that ...

LLDAS response rate observed in patients with SLE who received Descartes-08 in Phase 2 open-label trial reaching Month 3 follow-up (n=3) Disease remission reported as DORIS response seen in 2 out of 3 ...